These studies suggest promising paths to inhibit pathogenic TFH cells and IgE production in asthma, and also shed light on the development of novel immunotherapies in asthma patients by promoting Treg/TFR cell-mediated suppression of TFH cells. The gene discussed is TFRC; the disease is asthma.